268 related articles for article (PubMed ID: 10923761)
1. Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists.
Zhu H; Barr GA
Psychopharmacology (Berl); 2000 Jun; 150(3):325-36. PubMed ID: 10923761
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent.
Zhu H; Barr GA
Synapse; 2001 Jun; 40(4):282-93. PubMed ID: 11309844
[TBL] [Abstract][Full Text] [Related]
3. Protection from inorganic mercury effects on the in vivo dopamine release by ionotropic glutamate receptor antagonists and nitric oxide synthase inhibitors.
Vidal L; Durán R; Faro LF; Campos F; Cervantes RC; Alfonso M
Toxicology; 2007 Sep; 238(2-3):140-6. PubMed ID: 17624650
[TBL] [Abstract][Full Text] [Related]
4. Mediation of glutamatergic receptors and nitric oxide on striatal dopamine release evoked by anatoxin-a. An in vivo microdialysis study.
Campos F; Alfonso M; Vidal L; Faro LR; Durán R
Eur J Pharmacol; 2006 Oct; 548(1-3):90-8. PubMed ID: 16963020
[TBL] [Abstract][Full Text] [Related]
5. Role of nitric oxide synthase inhibitors and NMDA receptor antagonist in nicotine-induced behavioral sensitization in the rat.
Shim I; Kim HT; Kim YH; Chun BG; Hahm DH; Lee EH; Kim SE; Lee HJ
Eur J Pharmacol; 2002 May; 443(1-3):119-24. PubMed ID: 12044801
[TBL] [Abstract][Full Text] [Related]
6. Involvement of N-methyl-D-aspartate receptors and nitric oxide in the rostral ventromedial medulla in modulating morphine pain-inhibitory signals from the periaqueductal grey matter in rats.
Javanmardi K; Parviz M; Sadr SS; Keshavarz M; Minaii B; Dehpour AR
Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):585-9. PubMed ID: 16026519
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of acute morphine withdrawal in the neonatal rat by the competitive NMDA receptor antagonist LY235959.
Jones KL; Zhu H; Jenab S; Du T; Inturrisi CE; Barr GA
Neuropsychopharmacology; 2002 Mar; 26(3):301-10. PubMed ID: 11850145
[TBL] [Abstract][Full Text] [Related]
8. Methadone's effects on pentylenetetrazole-induced seizure threshold in mice: NMDA/opioid receptors and nitric oxide signaling.
Kazemi Roodsari S; Bahramnejad E; Rahimi N; Aghaei I; Dehpour AR
Ann N Y Acad Sci; 2019 Aug; 1449(1):25-35. PubMed ID: 30957236
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide synthase inhibitors attenuate acute and chronic morphine withdrawal response in the rat locus coeruleus: an in vivo voltammetric study.
Hall S; Milne B; Jhamandas K
Brain Res; 1996 Nov; 739(1-2):182-91. PubMed ID: 8955938
[TBL] [Abstract][Full Text] [Related]
10. Role of glutamate receptors and nitric oxide on the effects of glufosinate ammonium, an organophosphate pesticide, on in vivo dopamine release in rat striatum.
Faro LR; Ferreira Nunes BV; Alfonso M; Ferreira VM; Durán R
Toxicology; 2013 Sep; 311(3):154-61. PubMed ID: 23810826
[TBL] [Abstract][Full Text] [Related]
11. The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction.
Herman BH; Vocci F; Bridge P
Neuropsychopharmacology; 1995 Dec; 13(4):269-93. PubMed ID: 8747752
[TBL] [Abstract][Full Text] [Related]
12. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat.
Klamer D; Zhang J; Engel JA; Svensson L
Behav Brain Res; 2005 Apr; 159(1):95-103. PubMed ID: 15795002
[TBL] [Abstract][Full Text] [Related]
13. Effect of nitric oxide synthase inhibitors and molsidomine on the anticonvulsant activity of some antiepileptic drugs.
Baran L; Siwanowicz J; Przegaliński E
Pol J Pharmacol; 1997; 49(5):363-8. PubMed ID: 9566037
[TBL] [Abstract][Full Text] [Related]
14. Blockade of NMDA Receptors and Nitric Oxide Synthesis Potentiated Morphine-Induced Anti-Allodynia via Attenuating Pain-Related Amygdala pCREB/CREB Signaling Pathway.
Tolou-Dabbaghian B; Delphi L; Rezayof A
J Pain; 2019 Aug; 20(8):885-897. PubMed ID: 30707953
[TBL] [Abstract][Full Text] [Related]
15. Opiate physical dependence and N-methyl-D-aspartate receptors.
Noda Y; Nabeshima T
Eur J Pharmacol; 2004 Oct; 500(1-3):121-8. PubMed ID: 15464026
[TBL] [Abstract][Full Text] [Related]
16. Spinal NMDA receptor--nitric oxide mediation of the expression of morphine withdrawal symptoms in the rat.
Buccafusco JJ; Terry AV; Shuster L
Brain Res; 1995 May; 679(2):189-99. PubMed ID: 7633880
[TBL] [Abstract][Full Text] [Related]
17. Protection of methylmercury effects on the in vivo dopamine release by NMDA receptor antagonists and nitric oxide synthase inhibitors.
Faro LR; do Nascimento JL; Alfonso M; Durán R
Neuropharmacology; 2002 Apr; 42(5):612-8. PubMed ID: 11985818
[TBL] [Abstract][Full Text] [Related]
18. The importance of the number of NMDA receptors in the development of supersensitivity or tolerance to and dependence on morphine.
Koyuncuoglu H; Nurten A; Yamantürk P; Nurten R
Pharmacol Res; 1999 Apr; 39(4):311-9. PubMed ID: 10208762
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide synthase inhibitors. Preclinical studies of potential use for treatment of opioid withdrawal.
Vaupel DB; Kimes AS; London ED
Neuropsychopharmacology; 1995 Dec; 13(4):315-22. PubMed ID: 8747756
[TBL] [Abstract][Full Text] [Related]
20. Co-treatment with MK-801 potentiates naloxone-precipitated morphine withdrawal in the isolated spinal cord of the neonatal rat.
Bell JA; Beglan CL
Eur J Pharmacol; 1995 Dec; 294(1):297-301. PubMed ID: 8788444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
